NCT06832046 Evaluation of the "Intranasal Fentanyl" Protocol in Pediatric Surgical Emergencies at Strasbourg University Hospital
| NCT ID | NCT06832046 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Musculoskeletal Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-10-28 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-10-28 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Emergency trauma departments receive thousands of patients each year whose main symptom is pain. In recent years, intranasal fentanyl (FIN) has entered the therapeutic arsenal to treat pain in the emergency department. Various studies have validated its effectiveness for musculoskeletal pain as well as its tolerance and safety of use. Since then, new protocols have been implemented including this treatment. In This study, the investigators propose to retrospectively study the quality of prescription of intranasal fentanyl in the treatment of pain in the emergency department and the quality of monitoring of this treatment in current practice.
Eligibility Criteria
Inclusion Criteria: * Child \< 18 years old * Child treated in the pediatric emergency department of Strasbourg University Hospital * Child who has benefited from intranasal fentanyl between 08/01/2022 and 09/31/2024. * Child (and/or his/her parental authority) who has not expressed, after information, his/her (their) opposition to the reuse of his/her health data for the purposes of this research. Exclusion Criteria: * Refusal of the child (and/or his/her parent) to participate in the study * Patient's medical file not incomplete * Child not domiciled in France.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06832046 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 17 Years, studying Musculoskeletal Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06832046 currently recruiting?
Yes, NCT06832046 is actively recruiting participants. Contact the research team at Dimitar.tchomakov@chru-strasbourg.fr for enrollment information.
Where is the NCT06832046 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT06832046 clinical trial?
NCT06832046 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 500 participants.